Prolopa 50-12.5 · DIN 00522597 · 50 mg & 12.5 mg · capsule
General benefitMarketed · checked November 17, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
No interchangeable product listed in the Ontario extract
Prolopa 50-12.5 · DIN 00522597
Manufacturer: Hoffmann-La Roche Limited; listing date 1996-10-01
Health Canada: Marketed since 1981-12-31 · brand PROLOPA CAP 50-12.5 · ATC N04BA02 LEVODOPA AND DECARBOXYLASE INHIBITOR · form Capsule · route Oral · ingredients LEVODOPA 50 MG, BENSERAZIDE (BENSERAZIDE HYDROCHLORIDE) 12.5 MG · company Hoffmann-la roche limited · schedule Prescription
Prolopa 50-12.5: Formulary list price $0.35 per unit (the source does not state the unit; exact figure $0.3508). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00522597)
Source record
DIN 00522597: Prolopa 50-12.5
Raw flags: sec3=Y
Item: 920000037; group id 930; item number 2216; lccId None; manufacturer id HLR
Source form: Cap; strength: 50mg & 12.5mg
Recorded listing: General benefit
Source prices (unrounded): $0.3508; ministry $0.3508
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00522597
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=4459
Shortage status: not checked (no credentials)